동화약품(주) · KOSPI: 000020 · Pharmaceuticals and medicinal chemicals
No rule-based items found in the latest annual report or the last 12 months of filings. This is a limited automated check, not a clean bill of health.
| KRW | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | ₩361.1B | ₩464.9B | ₩496.4B |
| Operating income | ₩18.8B | ₩13.4B | ₩257M |
| Net income | ₩28.2B | ₩2.1B | ₩3.8B |
| Total assets | ₩558.5B | ₩619.6B | ₩642.2B |
| Total liabilities | ₩155.7B | ₩218.0B | ₩240.7B |
| Total equity | ₩402.8B | ₩401.7B | ₩401.4B |
| Share capital | ₩27.9B | ₩27.9B | ₩27.9B |
Consolidated statements · FY2025 operating margin 0.1% · liabilities to equity 60% · Annual report FY2025 (Korean original)
| Period | Auditor | Opinion |
|---|---|---|
| Term 97 (current) | 한울회계법인 | Unqualified |
| Term 96 (prior) | 한울회계법인 | Unqualified |
| Term 95 (two years prior) | 한울회계법인 | Unqualified |
No change history reported in the latest annual report.
| Date | Filing | Original |
|---|---|---|
| 2026-08-14 | Amended: Half-year report (2026.06) | DART |
| 2026-08-14 | Half-year report (2026.06) | DART |
| 2026-08-11 | Large shareholding (5%+) report | DART |
| 2026-07-30 | Fair trade compliance program status (notice) | DART |
| 2026-06-17 | Amended: Quarterly report (2026.03) | DART |
| 2026-06-01 | Corporate governance report | DART |
| 2026-05-15 | Quarterly report (2026.03) | DART |
| 2026-04-29 | Fair trade compliance program status (notice) | DART |
| 2026-03-26 | Annual general meeting results | DART |
| 2026-03-26 | Independent director appointment / dismissal / resignation | DART |
| 2026-03-18 | Annual report (2025.12) | DART |
| 2026-03-18 | Audit report submitted | DART |
| 2026-03-11 | Proxy solicitation reference document | DART |
| 2026-03-11 | Amended: Notice of shareholders meeting | DART |
| 2026-03-11 | Notice of shareholders meeting | DART |
| 2026-03-10 | Amended: Resolution to convene shareholders meeting | DART |
| 2026-03-09 | Change in shareholdings of largest shareholder | DART |
| 2026-02-24 | Resolution to convene shareholders meeting | DART |
| 2026-02-24 | Amended: Cash / in-kind dividend decision | DART |
| 2026-02-24 | Revenue or profit structure changed materially | DART |
Showing the 20 most recent of 27 filings. The full brief lists all of them.
For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).
Data generated 2026-09-16 from OpenDART.
This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.